What to expect when you take Lotemax and have Crying?

Do you take Lotemax and have Crying? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 16, 2018

307 reports have been studied.


Females aged 50 to 59 :

238 related reports were analyzed:

Most common symptoms:

Drug ineffective
  • 7.14% for females aged 50 (±5) who take Lotemax
Dyspnea
  • 5.46% for females aged 50 (±5) who take Lotemax
Eye irritation
  • 10.92% for females aged 50 (±5) who take Lotemax
Eye pain
  • 6.3% for females aged 50 (±5) who take Lotemax
Eye swelling
  • 5.04% for females aged 50 (±5) who take Lotemax
Fatigue
  • 5.04% for females aged 50 (±5) who take Lotemax
Headache
  • 6.72% for females aged 50 (±5) who take Lotemax
High blood pressure
  • 5.04% for females aged 50 (±5) who take Lotemax
Malaise
  • 5.04% for females aged 50 (±5) who take Lotemax
Nausea
  • 7.98% for females aged 50 (±5) who take Lotemax
Ocular hyperaemia
  • 7.98% for females aged 50 (±5) who take Lotemax
Pain
  • 5.04% for females aged 50 (±5) who take Lotemax
Rashes
  • 6.3% for females aged 50 (±5) who take Lotemax
Vision blurred
  • 7.14% for females aged 50 (±5) who take Lotemax

Most common co-existing conditions:

Eye inflammation
  • 7.98% for females aged 50 (±5) who take Lotemax
Gastroesophageal reflux disease
  • 5.04% for females aged 50 (±5) who take Lotemax
High blood pressure
  • 5.46% for females aged 50 (±5) who take Lotemax
Hypersensitivity
  • 6.3% for females aged 50 (±5) who take Lotemax
Immunodeficiency common variable
  • 5.88% for females aged 50 (±5) who take Lotemax
Rheumatoid arthritis
  • 5.88% for females aged 50 (±5) who take Lotemax
back to top

Males aged 50 to 59 :

69 related reports were analyzed:

Most common symptoms:

Eyelid oedema
  • 7.25% for males aged 50 (±5) who take Lotemax
Fatigue
  • 10.14% for males aged 50 (±5) who take Lotemax
Fever
  • 7.25% for males aged 50 (±5) who take Lotemax
Headache
  • 7.25% for males aged 50 (±5) who take Lotemax
High blood pressure
  • 13.04% for males aged 50 (±5) who take Lotemax
Insomnia
  • 8.7% for males aged 50 (±5) who take Lotemax
Nausea
  • 8.7% for males aged 50 (±5) who take Lotemax
Photosensitivity reaction
  • 7.25% for males aged 50 (±5) who take Lotemax

Most common co-existing conditions:

Crohn's disease
  • 7.25% for males aged 50 (±5) who take Lotemax
High blood cholesterol
  • 15.94% for males aged 50 (±5) who take Lotemax
High blood pressure
  • 11.59% for males aged 50 (±5) who take Lotemax
Hypersensitivity
  • 7.25% for males aged 50 (±5) who take Lotemax
Narcolepsy
  • 7.25% for males aged 50 (±5) who take Lotemax
Pain
  • 7.25% for males aged 50 (±5) who take Lotemax
back to top

Do you take Lotemax and have Crying:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

lotemax

Lotemax has active ingredients of loteprednol etabonate. It is often used in uveitis. (latest outcomes from Lotemax 2,354 users)

crying

Crying has been reported by people with depression, multiple sclerosis, stress and anxiety, pain, attention deficit hyperactivity disorder (latest reports from 29,380 Crying patients).

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.